Sickle Cell Disease in Basra: Evidence-Based evaluation and insigh

Sickle cell disease (SCD) should be framed at the outset as the major hemoglobinopathy burden in Basra. A large epidemiological analysis from southern Iraq showed that SCD constituted 68.58% of registered hemoglobinopathy cases in Basrah, with a reported general prevalence of 238 per 100,000 population and a sickle cell trait frequency reaching 6.5%. The same study described Basrah as hosting the largest cohort of hemoglobinopathy patients in Iraq, underscoring the need to approach SCD as a sustained public health priority rather than a sporadic specialist problem